4th Quarter - Report
340B HEALTH for 340B HEALTH
Firm
Client
Income
—
Expenses
$255,010
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
The 340B Drug Pricing Program, FY18 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, final rule and new proposed rule concerning 340B ceiling price calculations and manufacturer civil monetary penalties
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY IRVING DAVIS | — |
| KATHRYN DIBITETTO | — |
| GREG DOGGETT | — |
| DANA LAUREN GANSMAN | — |
| TED SLAFSKY | — |
| AMANDA SELLERS SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.